Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
26 hedge funds and large institutions have $17.3M invested in Zosano Pharma Corporation in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 8 closing their positions.
212% more capital invested
Capital invested by funds: $5.56M → $17.3M (+$11.8M)
150% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 8
73% more funds holding
Funds holding: 15 → 26 (+11)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.16M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.62M |
| 3 |
GTC
Ghost Tree Capital
New York
|
+$1.62M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.03M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$933K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$1.6M |
| 2 |
AC
Armistice Capital
New York
|
-$936K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$418K |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$212K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | -$42.2K | -35 | -97% |
|
|
NMC
27
NEA Management Company
Timonium,
Maryland
| – | -$1.6M | -2,933 | Closed |
|
|
AC
28
Armistice Capital
New York
| – | -$936K | -1,714 | Closed |
|
|
29
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$418K | -766 | Closed |
|
|
EAM
30
Eventide Asset Management
Boston,
Massachusetts
| – | -$212K | -389 | Closed |
|
|
SM
31
Sabby Management
Miami Beach,
Florida
| – | -$81K | -148 | Closed |
|
|
VC
32
Vivo Capital
Palo Alto,
California
| – | -$77K | -141 | Closed |
|
|
VKH
33
Virtu KCG Holdings
New York
| – | -$35K | -65 | Closed |
|
34
Renaissance Technologies
New York
| – | -$23K | -43 | Closed |
|
ZSAN Hedge Fund Activity: Q1 2017 in Review
26 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2017, worth a combined $17.3M — up 212% from $5.56M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ZSAN positions and 8 closed out — a net gain of 12 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $2.16M. The largest seller was NEA Management Company, exiting entirely with an estimated $1.6M sold.
- 26 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2017, up from 15 in Q4 2016.
- Funds reported $17.3M of Zosano Pharma Corporation stock for Q1 2017, up 212% quarter-over-quarter.
- 20 funds opened new Zosano Pharma Corporation positions in Q1 2017 and 8 closed out, a net change of +12 holders.
- The largest Zosano Pharma Corporation buyer in Q1 2017 was Opaleye Management, an estimated $2.16M added.
- The largest Zosano Pharma Corporation seller in Q1 2017 was NEA Management Company, an estimated $1.6M sold.
Based on aggregated 13F filings for Q1 2017.